HOME > ARCHIVE
ARCHIVE
- 2 Influenza Drugs Faced Shortage This Season
April 14, 2003
- RESEARCH & DEVELOPMENT NEWS IN BRIEF
April 14, 2003
- Kissei Licenses Mitiglinide to Choongwae of South Korea
April 14, 2003
- Matsumotokiyoshi's Profit Forecasts Revised Upward by Security Analysts
April 14, 2003
- Chugai to Focus on Proper Use Following Launch of Xeloda
April 14, 2003
- Sugi Pharmacy: Sales, Profits Increase Remarkably
April 14, 2003
- Toho Reorganizes with Kyoso Mirai Group
April 14, 2003
- OTC NEWS IN BRIEF
April 14, 2003
- EPS to Start CRA Dispatch Business
April 14, 2003
- Doctors Strongly Interested in Advanced Medical Devices: Survey
April 14, 2003
- BUSINESS NEWS IN BRIEF
April 14, 2003
- MEDICAL DIVICE NEWS IN BRIEF
April 14, 2003
- CDFS Recommends Designation of Bio-derived Products
April 7, 2003
- Janssen's Sales Top \50 Bil., 4th Double-Digit Growth in 4 Years: President Sekiguchi
April 7, 2003
- Patient Meal Market to Grow 25% by 2007: Report
April 7, 2003
- PRESS SEMINAR
April 7, 2003
- Otsuka Licenses Dry Powder Inhaler from Innovata Biomed
April 7, 2003
- 10% Elderly Copayment Puts Brake on Patient Visits: CareNet Survey
April 7, 2003
- Number of Drugstores Up 34% to 14,673 in 2002: METI Statistics
April 7, 2003
- Generics Will Cut Mevalotin Sales "No More than 10%" Sankyo
April 7, 2003
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
